As shown in Fig. 1A, we found that the expression level of XRCC2 was significantly increased in various cancers, including colon adenocarcinoma, rectum adenocarcinoma, and glioblastoma multiforme (GBM). Here, XRCC2 is linked to colon adenocarcinoma.